Compare ARK Genomic Revolution ETF (ARKG) vs iShares 3 7 Year Treasury Bond ETF (IEI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares 3 7 Year Treasury Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while iShares 3 7 Year Treasury Bond ETF trades at $116.77. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares 3 7 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | IEI | |
|---|---|---|
Sector | Sector/Thematic | Fixed Income |
52-Week High | $43.57 | $120.72 |
52-Week Low | $23.09 | $116.67 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
IEI (iShares 3-7 Year Treasury Bond ETF) trades at $116.77, down slightly by 0.06% amid broader market volatility. The technical picture remains bearish with moving averages signaling continued pressure, though oscillators show neutral momentum. Recent dividend payments of $0.36-$0.37 highlight the fund's income generation, while bond market uncertainty persists with mixed signals on Federal Reserve policy direction.
The outlook for IEI remains cautious as Treasury yields face upward pressure from inflation concerns and potential Fed rate hikes. While the ETF offers lower volatility than corporate bonds, competition from higher-yielding alternatives like Vanguard's bond ETFs presents headwinds. Key risks include interest rate sensitivity and shifting investor preferences toward higher-yield fixed income options.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares 3 7 Year Treasury Bond ETF
IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Read more on IEI →
